Local Expression of Interleukin-1 Receptor Antagonist by Plasmid DNA Improves Mortality and Decreases Myocardial Inflammation in Experimental Coxsackieviral Myocarditis
Authors:
Open Access
- 19 March 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 105 (11) , 1278-1281
Abstract
Background — The inflammatory cytokines have an important role in the pathogenesis of viral myocarditis. Inerleukin-1 (IL-1) is one of the major cytokines that modulate the outcome of viral infection. Among the methods for in vivo gene transfer, direct injection of plasmid DNA is one that is simple and feasible. In this study, we expressed human IL-1 receptor antagonist (hIL-1Ra) in the mouse heart by direct injection of a novel plasmid vector and evaluated its effects on coxsackieviral (CVB3) myocarditis. Methods and Results — A plasmid vector expressing hIL-1Ra (total 40 μg/mouse) was injected into the heart apex of 8-week-old inbred female Balb/C mice (day 3). On day 0, mice (IL-1Ra-CVB3, n=35) were infected intraperitoneally with 10 4 PFU of CVB3; control mice (pCK-CVB3, n=15) were injected with empty vector on day −3 and infected on day 0. hIL-1Ra was expressed in the heart, reached its peak on day 5, and persisted for 2 weeks. The 14-day survival rate of IL-1Ra-CVB3 was higher (77%) than that of controls (30%, P Conclusion — These results showed that direct injection of the expression plasmid vector into the heart was an effective method to transfer the cytokine gene in vivo, and expressed IL-1Ra in the heart can modulate the deleterious effect of the host immune response in viral myocarditis.Keywords
This publication has 8 references indexed in Scilit:
- Fulminant Coxsackieviral MyocarditisNew England Journal of Medicine, 2001
- Cytokine Gene Therapy for Myocarditis by In Vivo ElectroporationHuman Gene Therapy, 2001
- MyocarditisNew England Journal of Medicine, 2000
- Improved Expression of Vascular Endothelial Growth Factor by Naked DNA in Mouse Skeletal Muscles: Implication for Gene Therapy of Ischemic DiseasesBiochemical and Biophysical Research Communications, 2000
- Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathyNature Medicine, 1999
- A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3Journal of Virology, 1996
- Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3Journal of Virology, 1994
- Production of interleukin-1-receptor antagonist during experimental endotoxaemiaThe Lancet, 1991